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Abstract Pseudovasculitis, vasculitis-like syndromes,
vasculitis look-alikes, or mimics of vasculitis represent a
heterogeneous collection of disorders that are capable of
simulating vasculitis. Inappropriate diagnosis leads to
delay or absence of proper management and exposure to
potentially deleterious treatment modalities such as
corticosteroids and cytotoxic agents. We report the case
of ﬁbromuscular dysplasia suspected to be a polyarteritis
nodosa. The progression of the lesions visualized by the
ultrasonographic study and computed tomography (CT)
scan after 10 days of treatment led to an emergency
laparotomy. The possible deleterious role of steroids
given to treat the suspected vasculitis is discussed.
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Introduction
The diagnosis of vasculitis is usually based on pattern
recognition of the presenting clinical features, labora-
tory tests for some of them such as antineutrophil
cytoplasmic autoantibody (ANCA) determination,
angiographic imaging for medium and large artery vas-
culitis, and whenever possible biopsy proof [1]. Classi-
ﬁcation criteria were established in the 1990s; however,
when applied in the clinical setting, many initial clinical
presentations remain diﬃcult to classify. In these situa-
tions, the diﬀerential diagnosis should always include
pseudovasculitis.
Pseudovasculitis, vasculitis-like syndrome, or mimics
of vasculitis represent a heterogeneous collection of
disorders that are capable of simulating vasculitis. Some
conditions such as cardiac myxomas, cholesterol embo-
lization, subacute endocarditis, and ﬁbromuscular dys-
plasia are more apt to cause confusion, but numerous
conditions can also be misleading. The diagnosis of
pseudovasculitis requires a high index of suspicion.
However, inappropriate diagnosis leads to delay or ab-
sence of proper management and exposure to potentially
deleterious treatment modalities such as corticosteroids
and cytotoxic agents [2, 3].
We report the case of a patient with ﬁbromuscular
dysplasia, suspected to be polyarteritis nodosa (PAN),
whose abdominal vascular imaging evolution after
10 days of steroids led to an emergency laparotomy.
Case report
A 35-year-old woman was admitted to the hospital
because of diﬀuse abdominal pain of 6 days duration
without diarrhea and vomiting. She had no remarkable
past medical history except a history of allergy to anti-
spasmolytic drugs. She had felt increasingly tired for
several months, but she had not lost weight or com-
plained of headaches. On physical examination, the
patient’s pulse rate was 90 bpm, blood pressure was 160/
100 mmHg, and her temperature was 37C. Neither
anemia nor jaundice was observed. The abdomen was
soft, but tender to palpation. Signs of peritoneal irrita-
tion were absent. No abnormal cardiopulmonary
ﬁndings were appreciated. No abnormal neurological
sign was present. Laboratory work-up revealed mild
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leukocytosis without anemia. The erythrocyte sedimen-
tation rate (ESR) was 16 mm/h, the C-reactive protein
(CRP) level 23 mg/l, serum alanine aminotransferase
18 U/l, serum aspartate aminotransferase 13 U/l, blood
urea nitrogen 2.5 mmol/l, and serum creatinine
66 lmol/l. Amylase and lipase were in the normal range.
The coagulation tests including antiphospholipid anti-
bodies were in the normal range. Immunology tests for
rheumatoid factor, antinuclear antibodies, anti-double-
stranded DNA antibodies, antinucleoprotein antibodies,
cryoprecipitate, hepatitis C virus antibodies, and hepa-
titis B virus surface antigen were negative. The urine was
negative for protein; the sediment contained 0–2 red
cells, 10–20 white cells, and 0–2 hyaline, granular and
white cell casts per low power ﬁeld. An electrocardio-
gram was normal, and the radiograph of the chest
showed no abnormalities.
An ultrasonographic study of the abdomen revealed
an ‘‘inﬂammatory’’ mantle of the splenic artery and the
suspicion of dilatation of the celiac axis. A computed
tomography (CT) scan with contrast of the abdomen
and pelvis conﬁrmed the inﬂammatory mantle of the
splenic artery and one aneurysm of the celiac axis
(Fig. 1). In addition, the CT scan showed multiple ste-
nosis of the hepatic artery. Angio-MRI (magnetic reso-
nance imaging) and angiograms of the abdominal axis
conﬁrmed the CT scan ﬁndings. The thoracic and
abdominal aorta and the carotid axis were normal. The
diﬀerential diagnosis included vasculitis and other more
uncommon entities. Essentially based on the radiology
imaging, the diagnosis of PAN was suspected. The pa-
tient received 80 mg of prednisone. The abdominal
symptoms disappeared rapidly, and the patient was
discharged a few days later under close surveillance. Ten
days later she felt well. A new ultrasonographic study of
the abdomen planned to monitor the evolution of the
visceral arterial lesions revealed a signiﬁcant progression
of the celiac aneurysm and a new splenic arterial aneu-
rysm (Fig. 1). She was referred to the surgeon for a
laparotomy. The celiac aneurysm and the splenic artery
were resected and a splenectomy was performed. The
histological analysis showed architectural anomalies of
the wall arteries mainly located in the media. The medial
arterial wall contained excessive numbers of irregularly
Fig. 1 Computed tomography scan with contrast of the patient’s
abdomen. Top left: aneurysm of the celiac axis (Ø11.0 mm). Top
right: signiﬁcant progression of the aneurysms of the celiac axis
after 10 days of steroids (Ø17.2 mm). Bottom: new aneurysm of the
splenic artery before (left) and after 2 weeks of steroids (right)
(Ø9.2 mm)
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oriented smooth muscle cells, which led to broadening of
the wall. Other parts of the wall were very thin leading to
aneurysms. No inﬂammatory elements suggesting a
vasculitis were observed. The histological ﬁndings were
compatible with a ﬁbromuscular dysplasia (diﬀuse
medial ﬁbrodysplasia) (Fig. 2). The postoperative course
was uneventful and she was discharged 1 week later. CT
scan with contrast and an angio-MRI were performed
9 months later and revealed no signiﬁcant lesions in
other visceral arteries.
Discussion
The localization and the aspect of celiac, hepatic, and
splenic artery lesions visualized with the CT scan and
angiographies were compatible with the diagnosis of
vasculitis of medium or large arteries. Medium-sized
vessel vasculitides include PAN and Churg–Strauss
vasculitis; large vessel vasculitides include Takayasu’s
disease and gigantocellular arteritis. PAN was consid-
ered to be the most likely. The diﬀerential diagnoses
include pseudovasculitis syndromes such as ﬁbromus-
cular dysplasia or less probably Ehlers–Danlos
syndrome type IV, cholesterol embolization, or throm-
boangiitis obliterans.
The diagnosis of PAN is based on clinical, labora-
tory, imaging, and histological ﬁndings. PAN is a nec-
rotizing angiitis involving medium-sized arteries that is
characterized by predominant typical features including
skin lesions (palpable purpura, livedo reticularis,
necrotic lesions, and infarcts of the ﬁngertips),
Fig. 2 Histological
characteristics. Top: sequential
cross sections of the splenic
artery obtained at diﬀerent
levels. Sections in the lower row
are from areas of normal
diameter; in contrast, the three
sections in the upper row show
a large aneurysmal dilatation
caused by perimedial dissection.
H&E, ·1. Bottom: cross section
from the splenic artery showing
focal thickening alternating
with areas in which the media is
unusually thin. H&E, ·100. The
photomicrograph on the right
shows a detail of the media with
disorganized smooth muscle
cells dispersed within loose
connective tissue. H&E, ·200
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mononeuritis multiplex, and distinctive abnormalities of
renal sediment. Laboratory tests including antinuclear
antibodies, rheumatoid factor, ANCA, etc. are usually
negative. ESR and CRP are useful in longitudinal
evaluation of disease activity but are nonspeciﬁc and do
not correlate well with the presence or absence of active
disease in all patients [4, 5]. The gold standard for the
diagnosis of vasculitis is biopsy of the involved site. If
such a site is unavailable, angiography can be per-
formed. The classic clinical features were absent in our
young patient; however, gastrointestinal involvement is
not so uncommon and retrieved in more than half of the
patients with PAN [6]. Gastrointestinal symptoms such
as initial and exclusive features have been described in
PAN and they are challenging because of their nonspe-
ciﬁc nature and the requirement for mesenteric angiog-
raphy or surgical exploration [7]. The consequence of
mesenteric artery involvement can be disastrous with
infarction or aneurysmal rupture [6, 8–11]. Conﬁrmation
of the diagnosis requires invasive procedures, such as
angiography or even exploratory laparotomy, which are
not without risks in inﬂammatory tissue. High doses of
corticosteroids should be rapidly initiated.
In our patient, the laparotomy performed 10 days
later ﬁnally led to the diagnosis. The histology was
typical for a medial ﬁbromuscular dysplasia. Medial
ﬁbromuscular dysplasia occurs primarily in the distal
two-thirds of the renal artery but also throughout the
cervicocranial arterial system. Fibromuscular dysplasia
is detected less commonly in other visceral arteries
including the celiac, superior and inferior mesenteric,
hepatic, and splenic arteries like in our patient.
The management decisions are not always easy and
depend on the expertise available at the institution, the
presence or absence of symptoms, and the numbers and
size of aneurysms. Surgical intervention, aneurysm
embolization, or conservative management are the three
alternative therapeutic options, but prospective studies
are lacking to determine the optimalmanagement [12–14].
In this case, the role of 10 days of corticoids in the
rapid and deleterious evolution of the lesions remains an
open question. Corticosteroids have the potential to al-
ter both circulating volume and vascular resistance
leading to increased blood pressure. In addition, cor-
ticoids can directly modify the vessel wall by inhibiting
the smooth muscle cell chemotaxis and proliferation. In
our case, both mechanisms could have contributed to
weakening the abnormal wall arteries due to the ﬁbro-
muscular dysplasia lesions [15, 16].
Few case reports of visceral ﬁbromuscular dysplasia
have been described with an acute abdomen due to
aneurysmal rupture in patients with radiological and
laboratory features suggesting a vasculitic process. Most
of them have been described with the histological diag-
nosis of segmental mediolytic arteriopathy, a variant
form of ﬁbromuscular dysplasia [17–21].
In conclusion, clinicians and radiologists must be
circumspect in making the diagnosis of vasculitis by
relying solely or too heavily on radiographic imaging. If
immunosuppressive drug therapy is initiated, close fol-
low-up is recommended. In ﬁbromuscular dysplasia,
corticosteroid therapy can be directly and rapidly dele-
terious for the vascular wall, leading, as we speculate in
our case, to worsening of the lesions.
Take home message
Clinicians and radiologists must be circumspect in
making the diagnosis of vasculitis by relying solely or
too heavily on radiographic imaging.
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